Literature DB >> 8881910

Causes of death in osteogenesis imperfecta.

S J McAllion1, C R Paterson.   

Abstract

AIMS: To determine the causes of death in patients with osteogenesis imperfecta, excluding infants with the perinatal lethal form (type II).
METHODS: Seventy nine patients with known osteogenesis imperfecta were identified, 37 of whom had been seen clinically in life. Causes of death were identified from death certificates, postmortem reports, medical records, hospital consultants, relatives, and the Brittle Bone Society's records.
RESULTS: Patients with the milder types of osteogenesis imperfecta, I and IV, often had a normal lifespan and died of unrelated illnesses such as myocardial infarction and malignancy. In some of these patients and in many patients with the more severe type III disease, it was clear that osteogenesis imperfecta contributed significantly to death, almost certainly to many of the respiratory deaths and to deaths from cardiac failure due to kyphoscoliosis. Osteogenesis imperfecta also caused six deaths, directly or indirectly, due to basilar invagination of the skull. Osteogenesis imperfecta may have contributed to deaths from intracranial bleeding. Apparently minor traumatic incidents may have disastrous consequences in patients with this disorder.
CONCLUSIONS: Prompt care for respiratory infections and prevention of trauma in patients with osteogenesis imperfecta is essential.

Entities:  

Mesh:

Year:  1996        PMID: 8881910      PMCID: PMC500603          DOI: 10.1136/jcp.49.8.627

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

Review 1.  Osteogenesis imperfecta: translation of mutation to phenotype.

Authors:  P H Byers; G A Wallis; M C Willing
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

2.  Acute bilateral extradural hematomas in a case of osteogenesis imperfecta congenita.

Authors:  E Pozzati; M Poppi; G Gaist
Journal:  Neurosurgery       Date:  1983-07       Impact factor: 4.654

3.  Haemostatic studies in osteogenesis imperfecta.

Authors:  S A Evensen; L Myhre; H Stormorken
Journal:  Scand J Haematol       Date:  1984-08

4.  Clinical and genetic patterns in osteogenesis imperfecta.

Authors:  R Wynne-Davies; J Gormley
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

5.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

6.  Heterogeneity of osteogenesis imperfecta type I.

Authors:  C R Paterson; S McAllion; R Miller
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

7.  Subhyaloid hemorrhage in osteogenesis imperfecta tarda.

Authors:  M K Khalil
Journal:  Can J Ophthalmol       Date:  1983-08       Impact factor: 1.882

8.  Osteogenesis imperfecta: an expanding panorama of variants.

Authors:  D Sillence
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

9.  Osteogenesis imperfecta: a clinical study of the first ten years of life.

Authors:  U Vetter; B Pontz; E Zauner; R E Brenner; J Spranger
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

10.  Cardiovascular abnormalities in osteogenesis imperfecta.

Authors:  N J White; C G Winearls; R Smith
Journal:  Am Heart J       Date:  1983-12       Impact factor: 4.749

View more
  31 in total

Review 1.  Specific entities affecting the craniocervical region: osteogenesis imperfecta and related osteochondrodysplasias: medical and surgical management of basilar impression.

Authors:  Arnold H Menezes
Journal:  Childs Nerv Syst       Date:  2008-04-10       Impact factor: 1.475

2.  Superior odontoid migration in the Klippel-Feil patient.

Authors:  Dino Samartzis; Prakasam Kalluri; Jean Herman; John P Lubicky; Francis H Shen
Journal:  Eur Spine J       Date:  2006-12-15       Impact factor: 3.134

3.  The pathology of osteogenesis imperfecta.

Authors:  A J Freemont
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

4.  Impact of fracture characteristics and disease-specific complications on health-related quality of life in osteogenesis imperfecta.

Authors:  Masaki Matsushita; Kenichi Mishima; Satoshi Yamashita; Nobuhiko Haga; Sayaka Fujiwara; Keiichi Ozono; Takuo Kubota; Taichi Kitaoka; Naoki Ishiguro; Hiroshi Kitoh
Journal:  J Bone Miner Metab       Date:  2019-08-13       Impact factor: 2.626

Review 5.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

6.  Respiratory defects in the CrtapKO mouse model of osteogenesis imperfecta.

Authors:  Milena Dimori; Melissa E Heard-Lipsmeyer; Stephanie D Byrum; Samuel G Mackintosh; Richard C Kurten; John L Carroll; Roy Morello
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-05       Impact factor: 5.464

7.  An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.

Authors:  Arnold S Kristof; Basil J Petrof; Qutayba Hamid; Martin Kolb; Jennifer S Landry; Alex MacKenzie; Francis X McCormack; Inga J Murawski; Joel Moss; Frank Rauch; Ivan O Rosas; Adam J Shapiro; Benjamin M Smith; David Y Thomas; Bruce C Trapnell; Lisa R Young; Maimoona A Zariwala
Journal:  Ann Am Thorac Soc       Date:  2017-08

8.  Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.

Authors:  Ingo Grafe; Stefanie Alexander; Tao Yang; Caressa Lietman; Erica P Homan; Elda Munivez; Yuqing Chen; Ming Ming Jiang; Terry Bertin; Brian Dawson; Franklin Asuncion; Hua Zhu Ke; Michael S Ominsky; Brendan Lee
Journal:  J Bone Miner Res       Date:  2016-02-12       Impact factor: 6.741

Review 9.  Osteogenesis imperfecta: an update on clinical features and therapies.

Authors:  Ronit Marom; Brien M Rabenhorst; Roy Morello
Journal:  Eur J Endocrinol       Date:  2020-10       Impact factor: 6.664

10.  Generalized connective tissue disease in Crtap-/- mouse.

Authors:  Dustin Baldridge; Jennifer Lennington; MaryAnn Weis; Erica P Homan; Ming-Ming Jiang; Elda Munivez; Douglas R Keene; William R Hogue; Shawna Pyott; Peter H Byers; Deborah Krakow; Daniel H Cohn; David R Eyre; Brendan Lee; Roy Morello
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.